Skip to main content

Table 1 Patients’ characteristics of the two groups

From: Percutaneous stent placement for malignant hilar biliary obstruction: side-by-side versus stent-in-stent technique

Characteristics

SBS group

SIS group

p value

Pt. No.

38

27

 

Gender

  

0.30

 Male

19 (50.0)

10 (37.0)

 

 Female

19 (50.0)

17 (63.0)

 

Age (y)

63.0 ± 12.4

65.3 ± 13.5

0.48

ECOG

  

0.48

 0

3 (7.7)

2 (6.2)

 

 1

23 (61.5)

20 (75)

 

 2

12 (30.8)

5 (18.8)

 

Obstruction causes

  

0.72

 Cholangiocarcinoma

18 (47.3)

9 (33.4)

 

 Gallbladder cancer

9 (23.7)

8 (29.6)

 

 HCC

6 (15.8)

5 (18.5)

 

 Others

5 (13.2)

5 (18.5)

 

Bismuth classification

  

0.68

 Type II

9 (23.7)

8 (29.6)

 

 Type III

22 (57.9)

16 (59.3)

 

 Type IV

7 (18.4)

3 (11.1)

 

 Further chemotherapy

6 (15.8)

4 (14.8)

0.91

  1. Note-Values presented as mean ± standard deviation where applicable. Values in parentheses are percentages
  2. ECOG Eastern Cooperative Oncology Group, HCC Hepatocellular Carcinoma